Navigation Links
Center aims to cut obesity in black, Latino New Yorkers
Date:3/11/2010

NEW YORK (March 3, 2010) A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City's African-American and Latino communities.

"African-Americans and Latinos have been disproportionately affected by the obesity epidemic, and its related risks for diabetes and heart disease," says Dr. Mary Charlson, the center's director, the William T. Foley Distinguished Professor of Medicine at Weill Cornell Medical College, and chief of the Division of Clinical Epidemiology and Evaluative Sciences Research in the Department of Medicine and executive director of the Center for Integrative Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "To address obesity, we will focus on changing eating behaviors."

Stress, certain visual cues, even someone's mood can all have a substantial impact on behavior and eating, she continues. "By affecting changes in these areas we think people will be able to achieve sustainable weight loss."

The new center is a joint program among Weill Cornell Medical College, Cornell University in Ithaca, Lincoln Medical and Mental Health Center in the Bronx and Renaissance Health System in Manhattan.

Dr. Charlson will serve as principal investigator of a new study called Small Changes and Lasting Effects. It will take an interdisciplinary approach to lifestyle changes, with psychologists, medical sociologists, nutritionists and other experts working directly with community members in Harlem and the South Bronx to tailor personalized programs that are more likely to be successful than a blanket approach.

The team aims to develop mindful eating strategies aimed at reducing weight through small, sustained changes in eating behavior coupled with sustained increases in physical activity. Their goal is to affect a 7 percent
'/>"/>

Contact: Lezlie Greenberg
leg2003@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Finland to get a Center of Water Efficiency Excellence
2. USC chosen for $25 million NSF center
3. $25M NSF center established to investigate the creation of biological machines
4. Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women
5. TGen becomes center of excellence for Horizon Discoverys GENESIS and X-MAN technology
6. University Hospitals Case Medical Center testing gene therapy for Alzheimers disease
7. NTU and EDB launch S$50 million ($36 million) integrated circuit design research center
8. University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids
9. UAB bone center director wins distinguished service award from clinical pathology society
10. Air Force Center of Excellence awarded in nanostructures and improved cognition
11. DFG approves funding for 17 new collaborative research centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... Reinforcing its commitment to supporting high-quality cancer ... Foundation have again partnered with the American Association ... funding opportunities, the Landon Foundation-AACR INNOVATOR Award for ... Award for International Collaboration in Cancer Research. ...
... boost our understanding of the fragile marine environment, the ... for Environment, Fisheries & Aquaculture Science (Cefas) are launching ... existing collaboration between the two institutions and establish exciting ... climate change on the marine environment will influence much ...
... 10, 2008 Uncovering a rare, two-billion-year-old window into the ... have found our planets geological history is more complex than ... geosciences at UH, led a team of researchers in a ... new light on the mantle, the vast layer that lies ...
Cached Biology News:Landon Foundation-AACR INNOVATOR Awards 2Landon Foundation-AACR INNOVATOR Awards 3Landon Foundation-AACR INNOVATOR Awards 4New UEA-Cefas alliance launched 2Journey to the center of the earth: Discovery sheds light on mantle formation 2Journey to the center of the earth: Discovery sheds light on mantle formation 3
(Date:12/19/2014)... 18, 2014 LayerBio is an MIT ... wound care. The National Eye Institute (NEI) at the ... Phase I SBIR grant to develop a drug-eluting intraocular ... most common cause of vision loss in people over ... According to Dr. Ken Mandell, LayerBio’s Founder and CEO, ...
(Date:12/19/2014)... The empty capsules market is ... population and technological innovations in the empty capsules ... catalysing the growth of the empty capsules market. ... , Scope of Report , The report will ... entrants/smaller firms to gauge the pulse of the ...
(Date:12/19/2014)... Dec. 18, 2014 Relmada Therapeutics, Inc. (OTCQB: ... treatment of chronic pain, announced the results of its ... "This was a transformational year in Relmada,s history and ... our company," said Sergio Traversa , chief executive ... executed on key financial, human resource and clinical development ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... LLC has been awarded a Phase I Small Business ... Institute on Aging. The project is focused on identifying ... (fat) that are regulated by a calorie restricted ... at LifeGen, the technology developed under the NIH ...
... In honor of National Chemistry Week (NCW), ... in San Diego, California, has joined with Herbert Hoover ... of chemistry in our everyday lives. National ... American Chemical Society (ACS) to unite local ACS ...
... Md., Oct. 21 United Therapeutics Corporation (Nasdaq: ... its third quarter 2010 financial results before market open ... will host a half-hour teleconference on Thursday, October 28, ... accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. ...
Cached Biology Technology:LifeGen Technologies Awarded NIH Grant to Identify Biomarkers of a Calorie Restricted Diet in Adipose Tissue 2MicroConstants Celebrates National Chemistry Week by Teaching San Diego High School Students About the Drug Development Process 2